HomeGLENMARK • NSE
add
Glenmark Pharmaceuticals Ltd
Nakaraang pagsara
₹1,678.30
Sakop ng araw
₹1,671.00 - ₹1,704.50
Sakop ng taon
₹722.10 - ₹1,769.60
Market cap
478.68B INR
Average na Volume
1.35M
P/E ratio
-
Dividend yield
0.15%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 32.44B | -4.63% |
Gastos sa pagpapatakbo | 16.64B | -1.97% |
Net na kita | 3.40B | 126.94% |
Net profit margin | 10.49 | 137.87% |
Kita sa bawat share | 12.06 | 92.45% |
EBITDA | 6.28B | -0.20% |
Aktuwal na % ng binabayarang buwis | 26.41% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 16.59B | 12.91% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 78.48B | — |
Natitirang share | 282.15M | — |
Presyo para makapag-book | 6.04 | — |
Return on assets | — | — |
Return on capital | 12.95% | — |
Cash Flow
Net change in cash
| (INR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 3.40B | 126.94% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India. Wikipedia
Itinatag
1977
Website
Mga Empleyado
14,989
